Browse > Article

Acute Oral Toxicity and Pathogenicity of a Potential Probiotic Bacillus sp. A9184 Isolated from Soybean Paste  

Lim, Jong-Hwan (College of Veterinary Medicine, Chungnam National University)
Park, Byung-Kwon (College of Veterinary Medicine, Chungnam National University)
Kim, Myoung-Seok (College of Veterinary Medicine, Chungnam National University)
Rhee, Man-Hee (College of Veterinary Medicine, Kyungpook National University)
Park, Seung-Chun (College of Veterinary Medicine, Kyungpook National University)
Yun, Hyo-In (College of Veterinary Medicine, Chungnam National University)
Publication Information
Toxicological Research / v.20, no.4, 2004 , pp. 359-363 More about this Journal
Abstract
This study provides more information about the potential toxicological risk of Bacillus sp. A9184 isolated from soybean paste. The evaluation was based on the guidelines of acute oral toxicity/pathogenicity for microbial pesticide and was to get more comprehensive understanding on the acute toxicity of the potential probiotic in Sprgue-Dawley rats. No dead animal was observed in rats after single oral administration with bacteria ($10^8$ CFU per animal). There were neither no treatment-related changes in clinical signs, nor changes in body weight and body temperature as com-pared with the untreated group. All tested animal showed the increase in body weight with time. The results obtained in this study suggest that the potential probiotic, Bacillus sp. A9184, is non-toxic for rat.
Keywords
Bacillus sp.; Acute oral toxicity; Pathogenicity; Rats;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Elmer, GW. (2001): Probiotics: 'living drugs'. Am. J. Health Syst. Pharm., 58, 1101-1109
2 Perez-Chaia, A., Zarate, G. and Oliver, G. (1999): The probiotic properties of propionibacteria. Lait, 79, 175-185   DOI   ScienceOn
3 Zhou, J.S., Shu, Q., Rutherfund, K.J., Prasad, J., Gopal, PK and Gill, H.S. (2000): Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria. Food Ghem. Toxicol., 38, 153-161
4 Saarela, M., Lahteenmaki, L., Crittenden, R., Salminen, S and Mattila-Sandholm, T. (2002): Gut bacteria and health foods- the European perspective. Int. J. Food Microbiol., 78,99-117   DOI   ScienceOn
5 Donohue, D.C. and Salminen, S. (1996a): Safety assessment of probiotic bacteria. Asia Pac. J. Glin. Nutr., 5, 2528
6 EPA (1996): Microbial pesticide test guidelines, OPPTS 885.3050, acute oral toxicity/pathogenicity. the Office of Prevention, Pesticides and Toxic Substances, United States Environmental Protection Agency, USA
7 Verstegen, M.W. and Williams, BA (2002): Alternatives to the use of antibiotics as growth promoters for monogastric animals. Anim. Biotechnol., 13, 113-127
8 Farrar, W.E. Jr. (1963): Serious infections due to 'non-pathogenic' organisms of the genus Bacillus. Review of their status as pathogens. Am. J. Med., 34, 134-141   DOI   ScienceOn
9 Due, L.H., Hong, HA, Barbosa, T.M., Henriques, A.O. and Cutting, S.M. (2004): Characterization of Bacillus probiotics available for human use. Appl. Environ. Microbiol., 70, 2161-2171
10 Conway, P.L. (1996): Selection criteria for probiotic microorganisms. Asia Pac. J. Glin. Nutr., 5, 10-14
11 Salminen, S., von Wright, A., Morelli, L., Marteau, P., Brassart, D., de Vos, W.M., Fonden, R., Saxelin, M., Collins, K., Mogensen, G., Birkeland, S.E. and Mattila-Sandholm, T. (1998): Demonstration of safety of probiotics-a review. Int. J. Food Microbiol., 44, 93-106
12 Reid, G. and Friendship, R. (2002): Alternatives to antibiotic use: probiotics for the gut. Anim. Biotechnol., 13, 97-112
13 Rowland, I.R., Mallet, A.K. and Wise, A. (1983): A comparison of the activity of five microbial enzymes in cecal content from rates, mice, and hamsters, and response to dietary pectin. Toxicol. Appl. Pharmacol., 69, 143-148
14 Marteau, P, Minekus, M., Havenaar, R. and Huislnt, Ved, J.H.J. (1997): Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J. Dairy Sci., 80, 1031-1037
15 Mazza, P., Zani, F. and Martelli, P. (1992): Studies on the antibiotic resistance of Bacillus subtilis strains used in oral bacteriotherapy. Boll. Ghim. Farm., 131, 401-408
16 Mazza, P. (1994): The use of Bacillus subtilis as an antidiarrhoeal microorganism. Boll. Ghim. Farm., 133, 3-18
17 Berg, R.D. (1992): Translocation and the indigenous gut flora.ln: Fuller, R. (ed.), Probiotics: The Scientiffc Basis. Chapman & Hall, London, pp. 55-85
18 Donohue, D.C. and Salminen, S. (1996b): Safety of Lactobacillus GG (ATCC 53103). Nutr. Today, 31, 12s-15s
19 Ihde, D.C. and Armstrong, D. (1973): Clinical spectrum of infection due to Bacillus species. Am. J. Med., 55, 839-845   DOI   ScienceOn
20 Steffen, EK and Berg, RD. (1983): Relationship between cecal population levels of indigenous bacteria and translocation to the mesenteric lymph nodes. Intec. Immun., 39, 1215-1259